Tiziana Life Sciences Ltd is a biotechnology company focused on developing innovative therapies for diseases with significant unmet medical needs
Their research is primarily centered on the application of monoclonal antibodies and other biological agents to address conditions such as cancer, autoimmune disorders, and infectious diseases. By leveraging cutting-edge science and technology, Tiziana aims to create novel solutions that enhance patient outcomes and improve the quality of life for individuals suffering from debilitating health issues. The company is actively engaged in clinical trials and collaborations to bring their advancements from the lab to the clinic.
Tesla Inc (NASDAQTLSA) and SpaceX, chief executive officer, Elon Musk sparked a new controversy by saying that Jeff Bezos, the founder and executive chairman of Amazon.com, predicted President-elect Donald Trump's defeat and asked people to sell stake in Musk's companies, before the election.
Nuclear energy stocks and ETFs have come to the fore as ARK Invest's founder Cathie Wood reshared the firm's study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and rendered nuclear energy less cost-competitive than natural gas today.
Trading expert Anne-Marie Baiynd shared option trade ideas for Tesla on Benzinga's YouTube, discussing potential positive catalysts and bullish strategies.
